The metabolism of tumour related proteins

  • T. A. Waldmann
  • K. R. Mcintire
  • D. W. Dalgard
  • R. H. Adamson

Abstract

Over the past few years there has been an intense interest and excitement in studies of groups of serum proteins associated with neoplasms. These include myeloma and Bence—Jones proteins as well as a group of proteins termed oncofetal proteins. The oncofetal proteins are present in the biological fluids of the fetus and of patients with certain forms of cancer but are absent or in exceedingly low concentration in the serum of normal adults. The demonstration of such proteins provides valuable leads for basic research concerned with the nature of malignant transformation. In addition, the quantitation of these proteins is of great value in the diagnosis and monitoring of the treatment of certain forms of cancer. This is expecially true when simultaneous in vivo and in vitro measurements of rates of biosynthesis of these protein markers are used in approaches that permit the determination of the total body burden of tumour cells. In these latter studies, the total number of tumour cells producing a protein marker can be quantitated by determining 3 sets of parameters: (a) the serum concentration of the protein marker; (b) the total body synthetic rate of the protein marker determined by in vivo turnover procedures, and (c) the synthetic rate of the protein marker per milligram of tumour or per tumour cell determined using in vitro culture techniques. This approach has been applied to the study of multiple myeloma in order to define the total body burden of myeloma cells in patients with this disorder1,2.

Keywords

Hepatitis Albumin Agar Iodine Electrophoresis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Salmon, S. E. and Smith, B. A. J. Clin. Invest., 49 (1970), 1114–1121CrossRefGoogle Scholar
  2. 2.
    Sullivan, P. W. and Salmon, S. E. J. Clin. Invest., 51 (1972), 1697–1708CrossRefGoogle Scholar
  3. 3.
    Abelev, G. I. Adv. Cancer Res., 14 (1971), 295–358CrossRefGoogle Scholar
  4. 4.
    Gitlin, D., Perricelli, A. and Gitlin, G. M. Cancer Res., 32 (1972), 979–982Google Scholar
  5. 5.
    Masopust, J., Kithier, K., Fuchs, V., Kotal, L. and Radl, J. (1967) in Intrauterine dangers to the foetus, Horsky, J. and Stembera, A. K., eds., Excerpta Medica Foundation, Amsterdam, pp. 30–35Google Scholar
  6. 6.
    Abelev, G. I., Perova, S. D., Khramkova, N. I., Postnikova, Z. A. and Irlin, I. S. Transplantation, 1 (1963), 174–180CrossRefGoogle Scholar
  7. 7.
    Masopust, J., Kithier, K., Radl, J., Koutecky, J. and Kotal, L. Int. J. Cancer, 3 (1968), 364–373CrossRefGoogle Scholar
  8. 8.
    Alpert, E., Pinn, V. W. and Isselbacher, K. J. N. Engl. J. Med., 285 (1971), 1058–1059CrossRefGoogle Scholar
  9. 9.
    Bourreille, J., Metayer, P., Sauger, F., Matray, F. and Fondimare, A. Presse Med., 78 (1970), 1277–1278Google Scholar
  10. 10.
    Kozower, M., Fawaz, K. A., Miller, H. M. and Kaplan, M. M. N. Engl. J. Med., 285 (1971), 1059–1060CrossRefGoogle Scholar
  11. 11.
    Mehlman, D. J., Bulkley, B. H. and Wiernik, P. H. N. Engl. J. Med., 285 (1971), 1060–1061CrossRefGoogle Scholar
  12. 12.
    Waldmann, T. A. and McIntire, K. R. Cancer, 34 (1974) 1510–1515CrossRefGoogle Scholar
  13. 13.
    Nishi, S. Cancer Res., 30 (1970), 2507–2512Google Scholar
  14. 14.
    Sizaret, P. P., McIntire, K. R. and Princler, G. L. Cancer Res., 31 (1971), 1899–1902Google Scholar
  15. 15.
    McFarlane, A. S. Nature, 182 (1958), 53CrossRefGoogle Scholar
  16. 16.
    Gold, P. and Freedman, S. O. J. Exp. Med., 122 (1965), 467–481CrossRefGoogle Scholar
  17. 17.
    Braunstein, G. D., Vaitukaitis, J. L., Carbone, P. P. and Ross, G. T. Ann. Intern. Med., 78 (1973), 39–45CrossRefGoogle Scholar
  18. 18.
    Weintraub, B. D. and Rosen, S. W. J. Clin. Endocr., 32 (1971), 94–101CrossRefGoogle Scholar
  19. 19.
    Buffe, D., Rimbaut, C., Lemerle, J., Schweisguth, O. and Burtin, P. Int. J. Cancer, 5 (1970), 85–87CrossRefGoogle Scholar
  20. 20.
    Edynak, E. M., Old, L. J., Vrana, M. and Lardis, M. P. N. Engl. J. Med., 286 (1972), 1178–1183CrossRefGoogle Scholar
  21. 21.
    Waldmann, T. A. and Strober, W. Progr. Allergy, 13 (1969), 1–110Google Scholar
  22. 22.
    Schabel, F. M., Jr. Cancer Res., 29 (1969), 2384–2389Google Scholar
  23. 23.
    Skipper, H. E., Schabel, F. M., Jr., Mellet, L. B., Montgemery, J. A., Wilkoff, L. J., Lloyd, H. H. and Brockman, R. W. Cancer Chemother. Rep., 54 (1970), 431–450Google Scholar
  24. 1.
    Salmon, S. E. and Smith, B. A. Tumour immunoglobulin synthesis and total body tumour cell number in IgG multiple myelomas. J. Clin. Invest., 49 (1970), 1114CrossRefGoogle Scholar

Copyright information

© The Contributors 1976

Authors and Affiliations

  • T. A. Waldmann
  • K. R. Mcintire
  • D. W. Dalgard
  • R. H. Adamson

There are no affiliations available

Personalised recommendations